Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_33463 | 240 | 4.99 | Mlig455_023684 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.110/0.00054 |
PKD1L2 | Mlig455_023684 {REF} {Length: 12137} {Pfam: Polycystin cation channel [PF08016.14, score=271.5]; PKD domain [PF00801.22, score=88.3]; PLAT/LH2 domain [PF01477.25, score=72.6]; PKD domain [PF18911.2, score=49.9]; Ion transport protein [PF00520.33, score=46.0]; F5/8 type C domain [PF00754.27, score=33.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [RH, Score=263, Expect=2e-69]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=272, Expect=3e-72]} {Dmel: FBgn0050048, CG30048, [Score=57.4, Expect=3e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=144, Expect=2e-33]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=518, Expect=3e-147]} {RNA1509_5488} {RNA1310_100} {RNA815_3211} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.912 | 2.876 | 0.99976 | 1.00000 | |
RegionR2 | 6.11 | 2.876 | 0.00001 | 0.00054 | |
RegionR3 | 0.471 | 2.876 | 0.44805 | 0.96072 | |
RegionR4 | 0.12 | 2.876 | 0.57777 | 0.89468 | |
RegionR5 | 1.263 | 2.876 | 0.21488 | 0.51371 | |
RegionR6 | -4.555 | 2.876 | 0.99969 | 1.00000 | |
RegionR7 | -3.987 | 2.876 | 0.99957 | 1.00000 | |
RegionR8 | 3.491 | 2.876 | 0.02549 | 0.31095 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 4.156 | 2.876 | 0.50227 | 1.00000 | |
RegenerationR2 | -1.512 | 2.876 | 0.11439 | 0.52644 | |
RegenerationR3 | -1.479 | 2.876 | 0.24429 | 0.67860 | |
RegenerationR4 | -2.34 | 2.876 | 0.06185 | 0.39835 | |
RegenerationR5 | -2.746 | 2.876 | 0.02029 | 0.24665 | |
RegenerationR6 | 1.71 | 2.876 | 0.31015 | 0.65831 | |
RegenerationBL | 0.142 | 2.876 | 0.55891 | 0.91410 | |
RegenerationTP | 0.255 | 2.876 | 0.70838 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_33463 | 240 | 4.99 | Mlig455_023684 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.110/0.00054 |
PKD1L2 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_023684 {REF} {Length: 12137} {Pfam: Polycystin cation channel [PF08016.14, score=271.5]; PKD domain [PF00801.22, score=88.3]; PLAT/LH2 domain [PF01477.25, score=72.6]; PKD domain [PF18911.2, score=49.9]; Ion transport protein [PF00520.33, score=46.0]; F5/8 type C domain [PF00754.27, score=33.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [RH, Score=263, Expect=2e-69]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=272, Expect=3e-72]} {Dmel: FBgn0050048, CG30048, [Score=57.4, Expect=3e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=144, Expect=2e-33]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=518, Expect=3e-147]} {RNA1509_5488} {RNA1310_100} {RNA815_3211} |
2. | MligTC455_35258 | 2779 | 57.89 | Mlig455_040964 | Neo: - Age: Up-Down-Down Region-specific R2: 2.469 Region-enriched R2: 1.501/0.00133 |
4.642 | - | 0.790 | 0.923 | 0.971 | 0.970 | 0.988 | Mlig455_040964 {REF} {Length: 8259} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [Score=543, Expect=9e-160]} {RNA1509_16633, RNA1509_52679} {RNA1310_236.2, RNA1509_16633} {RNA1509_16633, RNA815_77.1} | |
3. | MligTC455_16749 | 454 | 9.45 | Mlig455_001550, Mlig455_046548 | Neo: - Age: logFC(26M/2M)=0.515 Region-specific R2: 4.360 Region-enriched R2: 3.409/0.00015 |
TRAF4 | 4.603 | - | 0.931 | 0.899 | 0.965 | 0.847 | 0.961 | Mlig455_001550 {REF} {Length: 4563} {Pfam: TRAF-type zinc finger [PF02176.20, score=81.2]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=27.3]; Seven in absentia protein family [PF03145.18, score=27.2]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=23.0]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=22.9]; zinc finger of C3HC4-type, RING [PF15227.8, score=20.4]; zf-RING of BARD1-type protein [PF14835.8, score=20.3]; Ring finger domain [PF13639.8, score=19.5]} {Human: ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=237, Expect=4e-72]} {Mouse: ENSMUSG00000017386, Traf4, TNF receptor associated factor 4, [Score=241, Expect=7e-74]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=164, Expect=1e-44]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [RH, Score=276, Expect=1e-87]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_20900} {RNA1310_14813, RNA1509_20900} {RNA1509_20900, RNA815_2335.1} Mlig455_046548 {REF} {Length: 3881} {Pfam: TRAF-type zinc finger [PF02176.20, score=81.2]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=27.3]; Seven in absentia protein family [PF03145.18, score=27.2]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=23.0]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=22.9]; zinc finger of C3HC4-type, RING [PF15227.8, score=20.4]; zf-RING of BARD1-type protein [PF14835.8, score=20.3]; Ring finger domain [PF13639.8, score=19.5]} {Human: ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=236, Expect=1e-71]} {Mouse: ENSMUSG00000017386, Traf4, TNF receptor associated factor 4, [Score=240, Expect=3e-73]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=164, Expect=9e-45]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [RH, Score=275, Expect=6e-87]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_20900} {RNA1310_14813} {RNA815_2335.1} |
4. | MligTC455_50464 | 64 | 1.34 | Mlig455_007906, Mlig455_008010 | Neo: - Age: - |
4.588 | 0.926 | - | 0.765 | 0.970 | 0.931 | 0.996 | Mlig455_007906 {REF} {Length: 3294} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1} Mlig455_008010 {REF} {Length: 1139} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1} |
|
5. | MligTC455_41130 | 1186 | 24.72 | Mlig455_000166, Mlig455_000179, Mlig455_067712 | Neo: - Age: Down-Up-Down Region-specific R2: 5.626 Region-enriched R2: 4.906/0.00009 Regeneration-downregulated R3: -5.200 Regeneration-depleted R3: -5.200 |
4.554 | 0.917 | - | 0.862 | 0.983 | 0.793 | 0.999 | Mlig455_000166 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_000179 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_067712 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} |
|
6. | MligTC455_42037 | 1931 | 40.23 | Mlig455_063391 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.444 Region-specific R2: 2.479 Region-enriched R2: 1.442/0.00136 |
4.536 | - | 0.860 | 0.901 | 0.896 | 0.921 | 0.958 | Mlig455_063391 {REF} {Length: 1482} {RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236} {RNA1310_24553, RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236} {RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236, RNA815_11766} | |
7. | MligTC455_33039 | 312 | 6.51 | Mlig455_032494 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.545/0.00267 |
PKDREJ | 4.473 | - | 0.770 | 0.854 | 0.926 | 0.949 | 0.974 | Mlig455_032494 {REF} {Length: 11952} {Pfam: Polycystin cation channel [PF08016.14, score=289.9]; REJ domain [PF02010.17, score=90.4]; PLAT/LH2 domain [PF01477.25, score=68.4]; PKD domain [PF00801.22, score=57.9]; PKD domain [PF18911.2, score=36.7]; Ion transport protein [PF00520.33, score=36.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=30.0]; WSC domain [PF01822.21, score=23.3]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=267, Expect=1e-70]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=292, Expect=3e-78]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=136, Expect=2e-31]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=297, Expect=4e-80]} {Smed: dd_Smed_v6_15525_0_1, dd_Smed_v6_15525_0_1, [Score=1504, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
8. | MligTC455_35259 | 2265 | 47.19 | Mlig455_040978 | Neo: - Age: Up-Down-Down Region-specific R2: 2.606 Region-enriched R2: 1.588/0.00387 |
ADGRL2 | 4.472 | - | 0.789 | 0.790 | 0.944 | 0.960 | 0.989 | Mlig455_040978 {REF} {Length: 10808} {TRANSSPLICED} {Pfam: PDZ domain [PF00595.26, score=86.9]; 7 transmembrane receptor (Secretin family) [PF00002.26, score=76.2]; PDZ domain [PF17820.3, score=67.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=52.3]; PDZ domain [PF13180.8, score=36.4]; ZU5 domain [PF00791.22, score=30.8]; Guanylate kinase [PF00625.23, score=22.4]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=174, Expect=1e-42]} {Mouse: ENSMUSG00000034917, Tjp3, tight junction protein 3, [RH, Score=172, Expect=9e-43]} {Dmel: FBgn0262614, pyd, polychaetoid, [RH, Score=232, Expect=8e-61]} {Celegans: WBGene00013683, zoo-1, ZO-1 (Zonula Occludens tight junctional protein) Ortholog, [Score=174, Expect=4e-43]} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [RH, Score=833, Expect=0.0]} {RNA1509_17602, RNA1509_52679, RNA1509_58629} {RNA1310_236.2, RNA1509_17602, RNA1509_58629} {RNA1509_17602, RNA1509_58629, RNA815_77.1} |
9. | MligTC455_31164 | 572 | 11.91 | Mlig455_029609, Mlig455_045673 | Neo: - Age: - |
4.466 | 0.799 | - | 0.860 | 0.861 | 0.968 | 0.978 | Mlig455_029609 {REF} {Length: 746} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=39.4]} {Smed: dd_Smed_v6_22533_0_1, dd_Smed_v6_22533_0_1, [Score=48.5, Expect=1e-06]} {RNA1310_96354} {RNA815_44390} Mlig455_045673 {REF} {Length: 2025} {RNA1509_21720} {RNA1310_14760} {RNA815_24583} |
|
10. | MligTC455_42994 | 1521 | 31.7 | Mlig455_035840 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.356 Region-enriched R2: 1.854/0.00052 |
4.45 | - | 0.717 | 0.901 | 0.860 | 0.990 | 0.982 | Mlig455_035840 {REF} {Length: 1436} {RNA1509_29485, RNA1509_42231} {RNA1310_26640, RNA1509_29485, RNA1509_42231} {RNA1509_29485, RNA1509_42231, RNA815_37260} | |
11. | MligTC455_53843 | 1448 | 30.17 | Mlig455_048664 | Neo: - Age: logFC(26M/2M)=0.488 |
4.387 | - | 0.888 | 0.821 | 0.826 | 0.886 | 0.966 | Mlig455_048664 {REF} {Length: 1660} {RNA1509_15580} {RNA1310_24090, RNA1509_15580} {RNA1509_15580, RNA815_10676.2} | |
12. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 4.366 | - | 0.709 | 0.954 | 0.894 | 0.838 | 0.971 | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
13. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 4.339 | - | 0.700 | 0.950 | 0.985 | 0.727 | 0.977 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
14. | MligTC455_47261 | 1918 | 39.96 | Mlig455_033946 | Neo: - Age: - Region-specific R2: 4.808 Region-enriched R2: 4.545/0.00000 |
4.33 | - | 0.703 | 0.709 | 0.950 | 0.975 | 0.993 | Mlig455_033946 {REF} {Length: 2098} {RNA1509_18239, RNA1509_26992, RNA1509_32368} {RNA1310_36725.1, RNA1509_18239, RNA1509_26992, RNA1509_32368} {RNA1509_18239, RNA1509_26992, RNA1509_32368, RNA815_10268.1} | |
15. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 4.325 | - | 0.711 | 0.843 | 0.920 | 0.859 | 0.992 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
16. | MligTC455_44970 | 1433 | 29.86 | Mlig455_019009 | Neo: - Age: Up-Down-Up Region-enriched R2: 1.095/0.00909 Regeneration-downregulated BL: -1.437 Regeneration-depleted BL: -1.437 |
ATP1B1 | 4.306 | - | 0.841 | 0.875 | 0.969 | 0.807 | 0.814 | Mlig455_019009 {REF} {Length: 4231} {TRANSSPLICED} {Pfam: Sodium / potassium ATPase beta chain [PF00287.20, score=91.0]} {Human: ENSG00000143153, ATP1B1, ATPase Na+/K+ transporting subunit beta 1, [Score=61.2, Expect=6e-10]} {Mouse: ENSMUSG00000026576, Atp1b1, ATPase, Na+/K+ transporting, beta 1 polypeptide, [Score=61.2, Expect=4e-10]} {Dmel: FBgn0032946, nrv3, nervana 3, [Score=89.4, Expect=8e-20]} {Celegans: WBGene00010117, nkb-3, Probable sodium/potassium-transporting ATPase subunit beta-3, [Score=84.3, Expect=3e-18]} {Smed: dd_Smed_v6_7917_0_1, dd_Smed_v6_7917_0_1, [Score=115, Expect=2e-29]} {RNA1509_10526, RNA1509_49181} {RNA1310_31711, RNA1509_10526, RNA1509_49181} {RNA1509_10526, RNA1509_49181, RNA815_17406} |
17. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 4.261 | - | 0.700 | 0.871 | 0.985 | 0.728 | 0.977 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
18. | MligTC455_53844 | 1403 | 29.24 | Mlig455_051626 | Neo: - |
4.255 | - | 0.882 | 0.734 | 0.794 | 0.877 | 0.968 | Mlig455_051626 {REF} {Length: 1671} {RNA1509_15580} {RNA1310_24090} {RNA815_10676.2} | |
19. | MligTC455_18599 | 119 | 2.47 | Mlig455_031197 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.553/0.00808 |
4.247 | - | 0.861 | 0.945 | 0.953 | 0.726 | 0.762 | Mlig455_031197 {REF} {Length: 1284} {RNA1310_35452} | |
20. | MligTC455_18891 | 275 | 5.73 | Mlig455_024941 | Neo: - Age: - Region-enriched R2: 2.016/0.02450 |
4.21 | 0.859 | - | 0.798 | 0.741 | 0.832 | 0.980 | Mlig455_024941 {REF} {Length: 394} {NoTransDecoderORF} {RNA1509_45136} {RNA1310_56753} {RNA815_28269} | |
21. | MligTC455_45665 | 1443 | 30.07 | Mlig455_011779 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.663 Region-enriched R2: 1.647/0.04427 Regeneration-depleted R6: -3.147 |
4.149 | 0.807 | 0.757 | 0.702 | 0.976 | - | 0.907 | Mlig455_011779 {REF} {Length: 735} {TRANSSPLICED} {RNA1509_33726} {RNA1310_46610, RNA1509_33726} {RNA1509_33726, RNA815_23273} | |
22. | MligTC455_44195 | 267 | 5.56 | Mlig455_057666 | Neo: - Age: logFC(26M/2M)=0.586 Region-enriched R2: 4.885/0.00002 |
4.125 | 0.759 | - | 0.816 | 0.774 | 0.787 | 0.989 | Mlig455_057666 {REF} {Length: 1757} {RNA1509_45654, RNA1509_50922} {RNA1310_26801.2, RNA1509_45654, RNA1509_50922} {RNA1509_45654, RNA1509_50922, RNA815_13136} | |
23. | MligTC455_26324 | 2227 | 46.4 | Mlig455_067472 | Neo: - Age: - Region-enriched R2: 4.150/0.00003 |
4.104 | 0.718 | - | 0.834 | 0.983 | 0.785 | 0.784 | Mlig455_067472 {REF} {Length: 918} {Smed: dd_Smed_v6_1588_0_1, dd_Smed_v6_1588_0_1, [Score=42.7, Expect=2e-06]} {RNA1509_6938} {RNA1310_54464.2} {RNA815_23024.2} | |
24. | MligTC455_53842 | 1222 | 25.46 | Mlig455_023890 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.345 Region-enriched R2: 1.546/0.01667 |
4.023 | - | 0.739 | 0.731 | 0.808 | 0.767 | 0.978 | Mlig455_023890 {REF} {Length: 1336} {RNA1509_15580} {RNA1310_22487.1} {RNA815_10676.1} | |
25. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
3.857 | - | - | 0.935 | 0.979 | 0.944 | 0.999 | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
26. | MligTC455_18564 | 196 | 4.08 | Mlig455_063527 | Neo: - Age: - Region-enriched R2: 2.416/0.01839 |
PRKG2 | 3.81 | - | 0.922 | - | 0.978 | 0.938 | 0.972 | Mlig455_063527 {REF} {Length: 2971} {Pfam: Protein kinase domain [PF00069.27, score=212.4]; Cyclic nucleotide-binding domain [PF00027.31, score=135.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=103.7]; Kinase-like [PF14531.8, score=24.8]} {Human: ENSG00000138669, PRKG2, protein kinase cGMP-dependent 2, [RH, Score=653, Expect=0.0]} {Mouse: ENSMUSG00000029334, Prkg2, protein kinase, cGMP-dependent, type II, [RH, Score=651, Expect=0.0]} {Dmel: FBgn0000442, Pkg21D, Protein kinase, cGMP-dependent at 21D, [RH, Score=662, Expect=0.0]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=655, Expect=0.0]} {Smed: dd_Smed_v6_6967_0_1, dd_Smed_v6_6967_0_1, [RH, Score=645, Expect=0.0]} {RNA1509_38353} {RNA1310_8466, RNA1509_38353} {RNA1509_38353, RNA815_6313} |
27. | MligTC455_33040 | 203 | 4.23 | Mlig455_032497 | Neo: - Age: logFC(26M/2M)=0.515 Region-enriched R2: 4.005/0.00408 |
PKD2L1 | 3.799 | - | - | 0.945 | 0.941 | 0.933 | 0.980 | Mlig455_032497 {REF} {Length: 3318} {Pfam: Polycystin cation channel [PF08016.14, score=293.1]; Ion transport protein [PF00520.33, score=39.7]} {Human: ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=236, Expect=4e-66]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=261, Expect=3e-73]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=131, Expect=5e-31]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=180, Expect=1e-47]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=641, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
28. | MligTC455_35583 | 48 | 0.99 | Mlig455_009953 | Neo: - Age: - |
3.773 | - | - | 0.906 | 0.943 | 0.929 | 0.995 | Mlig455_009953 {REF} {Length: 919} {Pfam: Lectin C-type domain [PF00059.23, score=25.9]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=61.6, Expect=2e-11]} {RNA1509_20946} {RNA1310_71370} {RNA815_4785.4} | |
29. | MligTC455_33832 | 112 | 2.34 | Mlig455_029411 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.300/0.00016 |
GLRA3 | 3.743 | - | - | 0.947 | 0.988 | 0.878 | 0.930 | Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433} |
30. | MligTC455_40118 | 72 | 1.5 | Mlig455_001236 | Neo: - Age: - |
KCNIP4 | 3.733 | - | - | 0.897 | 0.982 | 0.896 | 0.958 | Mlig455_001236 {REF} {Length: 1284} {Pfam: EF-hand domain pair [PF13499.8, score=42.4]; EF hand [PF00036.34, score=38.6]; EF-hand domain [PF13405.8, score=33.5]; EF hand [PF13202.8, score=31.2]; EF-hand domain pair [PF13833.8, score=28.7]} {Human: ENSG00000185774, KCNIP4, potassium voltage-gated channel interacting protein 4, [Score=122, Expect=2e-32]; ENSG00000182132, KCNIP1, potassium voltage-gated channel interacting protein 1, [Score=122, Expect=2e-32]; ENSG00000115041, KCNIP3, potassium voltage-gated channel interacting protein 3, [Score=119, Expect=1e-30]} {Mouse: ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=124, Expect=5e-33]; ENSMUSG00000029088, Kcnip4, Kv channel interacting protein 4, [Score=122, Expect=1e-32]} {Dmel: FBgn0013303, Nca, Neurocalcin, [Score=100, Expect=6e-25]} {Celegans: WBGene00003563, ncs-1, Neuronal calcium sensor 1, [Score=103, Expect=5e-26]} {Smed: dd_Smed_v6_9727_0_1, dd_Smed_v6_9727_0_1, [Score=122, Expect=8e-33]} {RNA1310_43225} {RNA815_33406} |
31. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
3.713 | - | - | 0.902 | 0.917 | 0.908 | 0.986 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
32. | MligTC455_19876 | 135 | 2.82 | Mlig455_024520, Mlig455_024523 | Neo: - Age: - |
3.713 | - | 0.824 | 0.945 | 0.974 | - | 0.970 | Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} |
|
33. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
3.712 | - | - | 0.953 | 0.962 | 0.804 | 0.993 | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
34. | MligTC455_49877 | 188 | 3.91 | Mlig455_027465 | Neo: - Age: - Region-enriched R2: 3.005/0.04141 |
AC254952.1 | 3.709 | - | 0.924 | - | 0.939 | 0.868 | 0.978 | Mlig455_027465 {REF} {Length: 2059} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=89.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=80.0]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=6e-38]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=144, Expect=1e-37]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=144, Expect=1e-37]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=144, Expect=9e-38]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=141, Expect=2e-36]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=141, Expect=1e-36]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=141, Expect=6e-37]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=139, Expect=5e-36]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=134, Expect=2e-34]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=132, Expect=4e-33]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=126, Expect=6e-32]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=131, Expect=2e-33]} {RNA1310_26175} {RNA815_7952} |
35. | MligTC455_27025 | 706 | 14.7 | Mlig455_054786, Mlig455_054878 | Neo: - Age: - Region-enriched R2: 3.519/0.00005 |
CD82 | 3.703 | - | - | 0.837 | 0.957 | 0.976 | 0.933 | Mlig455_054786 {REF} {Length: 2796} {Pfam: Tetraspanin family [PF00335.22, score=142.8]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=86.3, Expect=4e-19]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=94.0, Expect=3e-22]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=98.6, Expect=6e-24]} {Celegans: WBGene00006632, tsp-6, Tetraspanin, [Score=74.7, Expect=1e-15]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1310_8032.1, RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1509_20389, RNA1509_43644, RNA1509_56428, RNA815_3380.1} Mlig455_054878 {REF} {Length: 4398} {Pfam: Tetraspanin family [PF00335.22, score=143.7]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=84.7, Expect=2e-18]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=92.4, Expect=2e-21]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=99.8, Expect=4e-24]} {Celegans: WBGene00006643, tsp-17, TetraSPanin family, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_56428} {RNA1310_8032.2} {RNA815_3380.1} |
36. | MligTC455_38682 | 102 | 2.12 | Mlig455_039641 | Neo: - Age: - Region-enriched R2: 6.138/0.02363 |
SLC18A3 | 3.702 | - | - | 0.931 | 0.917 | 0.886 | 0.968 | Mlig455_039641 {REF} {Length: 3925} {Pfam: Major Facilitator Superfamily [PF07690.18, score=147.1]; Sugar (and other) transporter [PF00083.26, score=29.0]; LacY proton/sugar symporter [PF01306.21, score=20.2]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=469, Expect=9e-161]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=469, Expect=1e-160]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=513, Expect=2e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=486, Expect=2e-167]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_28397} {RNA815_32284.1} |
37. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 3.696 | - | - | 0.897 | 0.924 | 0.886 | 0.989 | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
38. | MligTC455_21757 | 26 | 0.53 | Mlig455_057867 | Neo: - Age: - |
3.693 | - | - | 0.871 | 0.929 | 0.894 | 0.999 | Mlig455_057867 {REF} {Length: 284} {NoTransDecoderORF} {RNA1310_117997} | |
39. | MligTC455_28559 | 6127 | 127.65 | Mlig455_028180 | Neo: - Age: - Region-specific R2: 2.829 Region-enriched R2: 1.854/0.00000 Regeneration-depleted BL: -1.839 |
SYT11 | 3.689 | - | - | 0.923 | 0.988 | 0.861 | 0.917 | Mlig455_028180 {REF} {Length: 2785} {Pfam: C2 domain [PF00168.32, score=161.4]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=305, Expect=7e-100]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=306, Expect=2e-100]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=351, Expect=1e-117]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=232, Expect=2e-72]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [RH, Score=399, Expect=2e-137]} {RNA1509_303} {RNA1310_7615, RNA1509_303} {RNA1509_303, RNA815_4825} |
40. | MligTC455_28560 | 6060 | 126.24 | Mlig455_028251 | Neo: - Age: - Region-specific R2: 2.839 Region-enriched R2: 1.867/0.00000 Regeneration-depleted BL: -1.887 |
SYT11 | 3.685 | - | - | 0.924 | 0.988 | 0.857 | 0.916 | Mlig455_028251 {REF} {Length: 2851} {Pfam: C2 domain [PF00168.32, score=161.3]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=304, Expect=1e-99]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=305, Expect=3e-100]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=353, Expect=3e-118]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=233, Expect=4e-73]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [RH, Score=397, Expect=6e-137]} {RNA1509_17703, RNA1509_303, RNA1509_58747} {RNA1310_7615, RNA1509_17703, RNA1509_58747} {RNA1509_17703, RNA1509_58747, RNA815_4825} |
41. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 3.681 | - | - | 0.856 | 0.937 | 0.902 | 0.986 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
42. | MligTC455_34524 | 155 | 3.22 | Mlig455_021291 | Neo: - Age: Down-Up-Down Region-specific R2: 4.905 Region-enriched R2: 4.200/0.01842 |
3.678 | - | - | 0.970 | 0.819 | 0.908 | 0.981 | Mlig455_021291 {REF} {Length: 1478} {NoTransDecoderORF} {RNA1509_56543} {RNA1310_26920, RNA1509_56543} {RNA1509_56543, RNA815_11718} | |
43. | MligTC455_19277 | 1013 | 21.11 | Mlig455_059600 | Neo: - Age: - Region-specific R2: 4.883 Region-enriched R2: 5.766/0.00000 |
3.671 | - | - | 0.952 | 0.865 | 0.894 | 0.960 | Mlig455_059600 {REF} {Length: 827} {NoTransDecoderORF} {RNA1509_43907} {RNA1310_81348} | |
44. | MligTC455_50567 | 146 | 3.04 | Mlig455_012858 | Neo: - Age: - Region-specific R2: 6.162 Region-enriched R2: 5.988/0.01054 |
3.668 | - | - | 0.962 | 0.988 | 0.929 | 0.789 | Mlig455_012858 {REF} {Length: 1282} {Pfam: F5/8 type C domain [PF00754.27, score=27.5]} {Smed: dd_Smed_v6_36585_0_1, dd_Smed_v6_36585_0_1, [RH, Score=64.3, Expect=4e-12]} {RNA1310_34633} {RNA815_12537} | |
45. | MligTC455_42376 | 61 | 1.27 | Mlig455_069890 | Neo: - Age: - |
3.665 | - | - | 0.891 | 0.878 | 0.961 | 0.935 | Mlig455_069890 {REF} {Length: 630} {TRANSSPLICED} {Pfam: PAN domain [PF00024.28, score=26.1]} {RNA1509_53783} {RNA1310_37190} {RNA815_24434} | |
46. | MligTC455_34525 | 52 | 1.08 | Mlig455_021566 | Neo: - Age: Down-Up-Down |
GNAI1 | 3.648 | - | 0.965 | 0.950 | 0.744 | - | 0.989 | Mlig455_021566 {REF} {Length: 3532} {Pfam: G-protein alpha subunit [PF00503.22, score=404.9]; ADP-ribosylation factor family [PF00025.23, score=56.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=20.1]; Gtr1/RagA G protein conserved region [PF04670.14, score=19.4]} {Human: ENSG00000127955, GNAI1, G protein subunit alpha i1, [Score=486, Expect=2e-171]; ENSG00000114353, GNAI2, G protein subunit alpha i2, [Score=481, Expect=3e-169]; ENSG00000065135, GNAI3, G protein subunit alpha i3, [Score=474, Expect=1e-166]} {Mouse: ENSMUSG00000057614, Gnai1, guanine nucleotide binding protein (G protein), alpha inhibiting 1, [Score=486, Expect=2e-171]; ENSMUSG00000032562, Gnai2, guanine nucleotide binding protein (G protein), alpha inhibiting 2, [Score=475, Expect=5e-167]; ENSMUSG00000000001, Gnai3, guanine nucleotide binding protein (G protein), alpha inhibiting 3, [Score=474, Expect=1e-166]} {Dmel: FBgn0001104, Galphai, G protein alpha i subunit, [Score=468, Expect=2e-164]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [Score=446, Expect=5e-156]} {Smed: dd_Smed_v6_12112_0_1, dd_Smed_v6_12112_0_1, [RH, Score=598, Expect=0.0]} {RNA1509_45426} {RNA1310_26920, RNA1509_45426} {RNA1509_45426, RNA815_11718} |
47. | MligTC455_38368 | 107 | 2.24 | Mlig455_026435, Mlig455_044757 | Neo: - Age: Up-Down-Down |
SSUH2 | 3.646 | - | - | 0.969 | 0.823 | 0.946 | 0.908 | Mlig455_026435 {REF} {Length: 1789} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [RH, Score=233, Expect=1e-72]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [RH, Score=195, Expect=1e-58]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=117, Expect=3e-29]} {RNA1509_6425} {RNA1310_32434} {RNA815_16161} Mlig455_044757 {REF} {Length: 883} {TRANSSPLICED} {RNA1509_28356} {RNA1310_61125} {RNA815_53103} |
48. | MligTC455_24536 | 120 | 2.5 | Mlig455_028895 | Neo: - Age: Up-Down-Down |
TRPA1 | 3.644 | - | - | 0.925 | 0.821 | 0.933 | 0.965 | Mlig455_028895 {REF} {Length: 4399} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=276.9]; Ankyrin repeats (many copies) [PF13637.8, score=235.5]; Ankyrin repeats (many copies) [PF13857.8, score=187.3]; Ankyrin repeat [PF00023.32, score=185.3]; Ankyrin repeat [PF13606.8, score=184.2]; Ion transport protein [PF00520.33, score=31.3]} {Human: ENSG00000104321, TRPA1, transient receptor potential cation channel subfamily A member 1, [Score=295, Expect=6e-83]} {Mouse: ENSMUSG00000032769, Trpa1, transient receptor potential cation channel, subfamily A, member 1, [Score=277, Expect=4e-77]} {Dmel: FBgn0035934, TrpA1, Transient receptor potential cation channel A1, [Score=305, Expect=2e-86]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=276, Expect=1e-76]} {Smed: dd_Smed_v6_20683_0_1, dd_Smed_v6_20683_0_1, [RH, Score=551, Expect=2e-178]} {RNA1509_56559} {RNA1310_3837.1} {RNA815_4441} |
49. | MligTC455_53240 | 1601 | 33.35 | Mlig455_025555 | Neo: - Age: - Region-specific R2: 4.178 Region-enriched R2: 2.883/0.00000 |
3.644 | - | - | 0.849 | 0.986 | 0.830 | 0.979 | Mlig455_025555 {REF} {Length: 2163} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=69.7, Expect=2e-14]} {Celegans: WBGene00010290, F58H1.7, [Score=64.7, Expect=4e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=168, Expect=3e-53]} {RNA1509_58542} {RNA1310_40950, RNA1509_58542} {RNA1509_58542, RNA815_19778.1} | |
50. | MligTC455_45350 | 92 | 1.93 | Mlig455_024760, Mlig455_058317, Mlig455_068656 | Neo: - Age: Up-Down-Down |
SLC17A6, SLC17A8 | 3.643 | - | - | 0.955 | 0.871 | 0.827 | 0.990 | Mlig455_024760 {REF} {Length: 2935} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_058317 {REF} {Length: 2971} {Pfam: Major Facilitator Superfamily [PF07690.18, score=157.7]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=534, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=521, Expect=8e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=531, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=526, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=485, Expect=1e-164]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=474, Expect=7e-162]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=585, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_068656 {REF} {Length: 3034} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} |
51. | MligTC455_46697 | 2841 | 59.19 | Mlig455_009247 | Neo: - Age: - Region-enriched R2: 2.282/0.00076 Regeneration-downregulated BL: -2.847 Regeneration-depleted BL: -2.847 |
3.639 | - | - | 0.848 | 0.964 | 0.879 | 0.948 | Mlig455_009247 {REF} {Length: 774} {Pfam: WD repeat binding protein EZH2 [PF11616.10, score=40.0]; NOPS (NUC059) domain [PF08075.13, score=34.4]} {RNA1509_12661} {RNA1310_96333} {RNA815_24028} | |
52. | MligTC455_51478 | 66 | 1.37 | Mlig455_057080 | Neo: - Age: - |
3.636 | - | - | 0.817 | 0.979 | 0.869 | 0.971 | Mlig455_057080 {REF} {Length: 1661} {Pfam: 7tm Chemosensory receptor [PF08395.14, score=33.2]; Trehalose receptor [PF06151.15, score=30.3]} {RNA1310_59684} {RNA815_43381} | |
53. | MligTC455_23957 | 33 | 0.68 | Mlig455_015196, Mlig455_068736 | Neo: - Age: - Region-enriched R2: 7.683/0.01527 |
3.624 | - | - | 0.851 | 0.893 | 0.881 | 0.999 | Mlig455_015196 {REF} {Length: 1138} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.8]} {RNA1509_30941} {RNA1310_34740} {RNA815_15663} Mlig455_068736 {REF} {Length: 1580} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=64.0]} {RNA1310_32395.1} {RNA815_15663} |
|
54. | MligTC455_24302 | 149 | 3.11 | Mlig455_035632 | Neo: - Age: Up-Down-Up |
KCNQ5 | 3.623 | - | - | 0.742 | 0.918 | 0.970 | 0.993 | Mlig455_035632 {REF} {Length: 2263} {Pfam: KCNQ voltage-gated potassium channel [PF03520.16, score=124.6]} {Human: ENSG00000185760, KCNQ5, potassium voltage-gated channel subfamily Q member 5, [Score=122, Expect=1e-28]; ENSG00000117013, KCNQ4, potassium voltage-gated channel subfamily Q member 4, [Score=121, Expect=2e-28]} {Mouse: ENSMUSG00000028033, Kcnq5, potassium voltage-gated channel, subfamily Q, member 5, [Score=121, Expect=1e-28]; ENSMUSG00000028631, Kcnq4, potassium voltage-gated channel, subfamily Q, member 4, [Score=119, Expect=4e-28]} {Dmel: FBgn0033494, KCNQ, KCNQ potassium channel, [Score=175, Expect=1e-46]} {Celegans: WBGene00002235, kqt-3, KQT-3 potassium channel; Potassium channel, KvQLT family, [Score=110, Expect=1e-25]} {Smed: dd_Smed_v6_17359_0_2, dd_Smed_v6_17359_0_2, [Score=186, Expect=2e-52]} {RNA1509_34272} {RNA1310_3730.1} {RNA815_2787} |
55. | MligTC455_18506 | 59 | 1.23 | Mlig455_038054 | Neo: - Age: Down-Up-Down |
SP9 | 3.622 | - | - | 0.937 | 0.847 | 0.841 | 0.997 | Mlig455_038054 {REF} {Length: 3168} {Pfam: Zinc-finger double domain [PF13465.8, score=49.0]; Zinc finger, C2H2 type [PF00096.28, score=40.9]; C2H2-type zinc finger [PF13894.8, score=26.8]} {Human: ENSG00000217236, SP9, Sp9 transcription factor, [RH, Score=202, Expect=4e-59]; ENSG00000164651, SP8, Sp8 transcription factor, [RH, Score=202, Expect=5e-59]} {Mouse: ENSMUSG00000068859, Sp9, trans-acting transcription factor 9, [RH, Score=202, Expect=3e-59]; ENSMUSG00000048562, Sp8, trans-acting transcription factor 8, [RH, Score=201, Expect=9e-59]} {Dmel: FBgn0020378, Sp1, [RH, Score=198, Expect=6e-56]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [Score=137, Expect=1e-35]} {Smed: dd_Smed_v6_17385_0_1, dd_Smed_v6_17385_0_1, [RH, Score=160, Expect=5e-46]} {RNA1310_42373} |
56. | MligTC455_26255 | 126 | 2.63 | Mlig455_053706 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.424/0.00107 |
FZD5 | 3.617 | - | - | 0.859 | 0.855 | 0.904 | 0.999 | Mlig455_053706 {REF} {Length: 3671} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=393.1]; Fz domain [PF01392.24, score=105.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [RH, Score=607, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=600, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [RH, Score=562, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [RH, Score=412, Expect=5e-137]} {Smed: dd_Smed_v6_11823_0_1, dd_Smed_v6_11823_0_1, [RH, Score=551, Expect=0.0]} {RNA1509_49831} {RNA1310_28187, RNA1509_49831} {RNA1509_49831, RNA815_16996} |
57. | MligTC455_35895 | 102 | 2.12 | Mlig455_063971 | Neo: - Age: - |
RYK | 3.615 | - | - | 0.909 | 0.884 | 0.854 | 0.968 | Mlig455_063971 {REF} {Length: 3496} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=209.4]; WIF domain [PF02019.20, score=109.7]; Protein kinase domain [PF00069.27, score=79.1]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=1e-55]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [RH, Score=202, Expect=2e-55]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=239, Expect=4e-69]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [Score=179, Expect=6e-48]} {Smed: dd_Smed_v6_12594_0_2, dd_Smed_v6_12594_0_2, [Score=201, Expect=3e-55]} {RNA1509_58811} {RNA1310_6671.2} {RNA815_41921} |
58. | MligTC455_46394 | 8810 | 183.54 | Mlig455_054818, Mlig455_054826 | Neo: - Age: - Region-specific R2: 1.771 Region-enriched R2: 1.255/0.00038 |
PKD2 | 3.604 | - | - | 0.760 | 0.907 | 0.957 | 0.980 | Mlig455_054818 {REF} {Length: 2992} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.7]; Ion transport protein [PF00520.33, score=93.3]; EF hand [PF00036.34, score=32.7]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=750, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=747, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=1e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=380, Expect=6e-120]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=733, Expect=0.0]} {RNA1509_1615} {RNA1310_21296.2, RNA1509_1615} {RNA1509_1615, RNA815_3158.1} Mlig455_054826 {REF} {Length: 3118} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.7]; Ion transport protein [PF00520.33, score=93.4]; EF hand [PF00036.34, score=32.6]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=754, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=751, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=2e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=769, Expect=0.0]} {RNA1509_13522} {RNA1310_21296.2} {RNA815_3158.1} |
59. | MligTC455_15586 | 179 | 3.72 | Mlig455_061074 | Neo: - Age: - Region-enriched R2: 6.557/0.00000 |
3.599 | - | - | 0.958 | 0.954 | 0.789 | 0.898 | Mlig455_061074 {REF} {Length: 997} {Dmel: FBgn0013467, igl, igloo, [Score=43.5, Expect=3e-06]} {Smed: dd_Smed_v6_4783_0_82, dd_Smed_v6_4783_0_82, [Score=70.1, Expect=6e-16]} {RNA1509_36803} {RNA1310_35463} {RNA815_8499} | |
60. | MligTC455_42510 | 125 | 2.6 | Mlig455_025998, Mlig455_070424 | Neo: - |
3.595 | - | - | 0.797 | 0.880 | 0.922 | 0.996 | Mlig455_025998 {REF} {Length: 1369} {RNA1310_73875.1} Mlig455_070424 {REF} {Length: 1082} {RNA1310_73875.1} |
|
61. | MligTC455_51764 | 938 | 19.55 | Mlig455_016061 | Neo: - Age: - Region-specific R2: 2.881 Region-enriched R2: 1.672/0.00180 |
3.593 | - | - | 0.799 | 0.929 | 0.914 | 0.951 | Mlig455_016061 {REF} {Length: 649} {RNA1509_58232} {RNA1310_60107.1, RNA1509_58232} {RNA1509_58232, RNA815_31573} | |
62. | MligTC455_26254 | 174 | 3.62 | Mlig455_034978 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.366 Region-enriched R2: 5.463/0.00000 Regeneration-downregulated R4: -3.454 Regeneration-depleted R4: -3.454 |
FZD5 | 3.591 | - | - | 0.853 | 0.880 | 0.866 | 0.992 | Mlig455_034978 {REF} {Length: 3353} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=393.1]; Fz domain [PF01392.24, score=105.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [RH, Score=607, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=600, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [RH, Score=562, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [RH, Score=412, Expect=5e-137]} {Smed: dd_Smed_v6_11823_0_1, dd_Smed_v6_11823_0_1, [RH, Score=551, Expect=0.0]} {RNA1509_49831} {RNA1310_28187} {RNA815_16996} |
63. | MligTC455_45039 | 168 | 3.49 | Mlig455_040482, Mlig455_040487 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.332/0.02336 |
3.591 | - | - | 0.806 | 0.854 | 0.932 | 0.999 | Mlig455_040482 {REF} {Length: 1774} {RNA1310_20941} {RNA815_45079} Mlig455_040487 {REF} {Length: 5763} {tRNA: Val(CAC),pseudo, score=20.2} {Celegans: WBGene00022195, Y71H2B.5, [Score=146, Expect=8e-36]} {Smed: dd_Smed_v6_16438_0_2, dd_Smed_v6_16438_0_2, [Score=188, Expect=1e-49]} {RNA1509_21228} {RNA1310_20941} {RNA815_45079} |
|
64. | MligTC455_19266 | 1038 | 21.61 | Mlig455_004528, Mlig455_028530 | Neo: - Age: - Region-specific R2: 2.706 Region-enriched R2: 1.766/0.00005 |
NCALD | 3.585 | - | - | 0.858 | 0.952 | 0.870 | 0.905 | Mlig455_004528 {REF} {Length: 3958} {tRNA: Val(CAC),pseudo, score=38.6} {Pfam: EF-hand domain pair [PF13499.8, score=74.4]; EF hand [PF00036.34, score=71.3]; EF-hand domain [PF13405.8, score=66.3]; EF hand [PF13202.8, score=62.7]; EF-hand domain pair [PF13833.8, score=50.8]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=22.1]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=19.3]} {Human: ENSG00000104490, NCALD, neurocalcin delta, [Score=194, Expect=4e-63]; ENSG00000115756, HPCAL1, hippocalcin like 1, [Score=191, Expect=1e-61]; ENSG00000121905, HPCA, hippocalcin, [Score=185, Expect=1e-59]} {Mouse: ENSMUSG00000051359, Ncald, neurocalcin delta, [Score=194, Expect=2e-63]; ENSMUSG00000071379, Hpcal1, hippocalcin-like 1, [Score=191, Expect=8e-62]; ENSMUSG00000028785, Hpca, hippocalcin, [Score=185, Expect=1e-59]} {Dmel: FBgn0036926, CG7646, [RH, Score=221, Expect=6e-74]} {Celegans: WBGene00003564, ncs-2, Neuronal calcium sensor 2, [Score=238, Expect=6e-81]} {Smed: dd_Smed_v6_5266_0_1, dd_Smed_v6_5266_0_1, [RH, Score=359, Expect=8e-129]} {RNA1509_14564} {RNA1310_18405, RNA1509_14564} {RNA1509_14564, RNA815_10180.1} Mlig455_028530 {REF} {Length: 3453} {tRNA: Val(CAC),pseudo, score=38.6} {Pfam: EF-hand domain pair [PF13499.8, score=74.4]; EF hand [PF00036.34, score=71.3]; EF-hand domain [PF13405.8, score=66.3]; EF hand [PF13202.8, score=62.7]; EF-hand domain pair [PF13833.8, score=50.8]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=22.1]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=19.3]} {Human: ENSG00000104490, NCALD, neurocalcin delta, [Score=194, Expect=4e-63]; ENSG00000115756, HPCAL1, hippocalcin like 1, [Score=191, Expect=1e-61]; ENSG00000121905, HPCA, hippocalcin, [Score=185, Expect=1e-59]} {Mouse: ENSMUSG00000051359, Ncald, neurocalcin delta, [Score=194, Expect=2e-63]; ENSMUSG00000071379, Hpcal1, hippocalcin-like 1, [Score=191, Expect=8e-62]; ENSMUSG00000028785, Hpca, hippocalcin, [Score=185, Expect=1e-59]} {Dmel: FBgn0036926, CG7646, [RH, Score=221, Expect=6e-74]} {Celegans: WBGene00003564, ncs-2, Neuronal calcium sensor 2, [Score=238, Expect=6e-81]} {Smed: dd_Smed_v6_5266_0_1, dd_Smed_v6_5266_0_1, [RH, Score=359, Expect=8e-129]} {RNA1509_13995, RNA1509_14564, RNA1509_30926} {RNA1310_18405, RNA1509_13995, RNA1509_30926} {RNA1509_13995, RNA1509_30926, RNA815_10180.1} |
65. | MligTC455_20390 | 87 | 1.82 | Mlig455_051716 | Neo: - Age: - |
SLC1A2 | 3.583 | - | - | 0.931 | 0.837 | 0.859 | 0.956 | Mlig455_051716 {REF} {Length: 4683} {Pfam: Sodium:dicarboxylate symporter family [PF00375.20, score=432.6]} {Human: ENSG00000110436, SLC1A2, solute carrier family 1 member 2, [RH, Score=530, Expect=0.0]} {Mouse: ENSMUSG00000005089, Slc1a2, solute carrier family 1 (glial high affinity glutamate transporter), member 2, [RH, Score=545, Expect=0.0]} {Dmel: FBgn0026439, Eaat1, Excitatory amino acid transporter 1, [RH, Score=375, Expect=4e-124]} {Celegans: WBGene00001620, glt-1, Excitatory amino acid transporter, [RH, Score=517, Expect=1e-179]} {Smed: dd_Smed_v6_7570_0_1, dd_Smed_v6_7570_0_1, [RH, Score=611, Expect=0.0]} {RNA1509_31315} {RNA1310_5180} {RNA815_8754} |
66. | MligTC455_46698 | 2235 | 46.56 | Mlig455_009652 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.372/0.00045 Regeneration-depleted TP: -3.177 |
3.581 | - | - | 0.826 | 0.955 | 0.872 | 0.928 | Mlig455_009652 {REF} {Length: 763} {Pfam: WD repeat binding protein EZH2 [PF11616.10, score=33.2]; NOPS (NUC059) domain [PF08075.13, score=29.1]} {RNA1509_45891} {RNA1310_92759} {RNA815_24028} | |
67. | MligTC455_41036 | 281 | 5.86 | Mlig455_057198 | Neo: - Age: - Region-specific R2: 5.284 Region-enriched R2: 4.243/0.00075 |
3.578 | - | - | 0.929 | 0.849 | 0.807 | 0.993 | Mlig455_057198 {REF} {Length: 538} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.9]} {RNA1509_42071} {RNA1310_74103, RNA1509_42071} {RNA1509_42071, RNA815_38377} | |
68. | MligTC455_40352 | 49 | 1.03 | Mlig455_024410 | Neo: - Age: - |
3.577 | - | - | 0.837 | 0.958 | 0.834 | 0.948 | Mlig455_024410 {REF} {Length: 1509} {TRANSSPLICED} {RNA1310_29008} {RNA815_41596} | |
69. | MligTC455_41540 | 190 | 3.96 | Mlig455_060056 | Neo: - Age: - Region-enriched R2: 6.605/0.00196 |
GLUL | 3.575 | - | - | 0.763 | 0.844 | 0.969 | 0.999 | Mlig455_060056 {REF} {Length: 1355} {Pfam: Glutamine synthetase, catalytic domain [PF00120.26, score=57.3]; Glutamine synthetase, beta-Grasp domain [PF03951.21, score=47.5]} {Human: ENSG00000135821, GLUL, glutamate-ammonia ligase, [RH, Score=511, Expect=1e-180]} {Mouse: ENSMUSG00000026473, Glul, glutamate-ammonia ligase (glutamine synthetase), [RH, Score=511, Expect=0.0]} {Dmel: FBgn0001145, Gs2, Glutamine synthetase 2, [RH, Score=511, Expect=0.0]} {Celegans: WBGene00001604, gln-3, Glutamine synthetase, [RH, Score=515, Expect=0.0]} {Smed: dd_Smed_v6_896_0_1, dd_Smed_v6_896_0_1, [RH, Score=545, Expect=0.0]} {RNA1509_47000} {RNA1310_22329.2} {RNA815_4116.6} |
70. | MligTC455_20574 | 3347 | 69.74 | Mlig455_021418 | Neo: - Age: - |
PCSK2 | 3.571 | - | - | 0.854 | 0.993 | 0.805 | 0.919 | Mlig455_021418 {REF} {Length: 1212} {Pfam: Peptidase S8 pro-domain [PF16470.7, score=47.7]} {Human: ENSG00000125851, PCSK2, proprotein convertase subtilisin/kexin type 2, [Score=53.9, Expect=2e-08]} {Mouse: ENSMUSG00000027419, Pcsk2, proprotein convertase subtilisin/kexin type 2, [Score=52.8, Expect=4e-08]} {Dmel: FBgn0023179, amon, amontillado, [Score=55.8, Expect=2e-09]} {Celegans: WBGene00001172, egl-3, Neuroendocrine convertase 2, [Score=61.2, Expect=3e-11]} {Smed: dd_Smed_v6_1566_0_1, dd_Smed_v6_1566_0_1, [Score=65.1, Expect=1e-12]} {RNA1509_15978} {RNA1310_7333.1} {RNA815_2403.2} |
71. | MligTC455_44513 | 1822 | 37.96 | Mlig455_044390 | Neo: - Age: Down-Up-Up Region-specific R2: 2.967 Region-enriched R2: 2.054/0.00008 |
3.562 | 0.876 | - | - | 0.952 | 0.839 | 0.895 | Mlig455_044390 {REF} {Length: 727} {Smed: dd_Smed_v6_5576_0_1, dd_Smed_v6_5576_0_1, [Score=93.2, Expect=5e-25]} {RNA1509_30750, RNA1509_53240, RNA1509_6792} {RNA1310_36193, RNA1509_30750, RNA1509_53240, RNA1509_6792} {RNA1509_30750, RNA1509_53240, RNA1509_6792, RNA815_16957} | |
72. | MligTC455_48218 | 1632 | 34 | Mlig455_054782, Mlig455_054874 | Neo: - Age: Down-Down-Up Region-specific R2: 3.792 Region-enriched R2: 2.673/0.00000 Regeneration-downregulated BL: -2.255 Regeneration-depleted BL: -2.255 |
3.56 | - | - | 0.928 | 0.955 | 0.761 | 0.916 | Mlig455_054782 {REF} {Length: 1928} {RNA1509_16585} {RNA1310_35143} {RNA815_1375.1} Mlig455_054874 {REF} {Length: 2445} {RNA1509_16585} {RNA1310_35143, RNA1509_16585} {RNA1509_16585, RNA815_1375.1} |
|
73. | MligTC455_40290 | 58 | 1.21 | Mlig455_058728 | Neo: - Age: - Region-enriched R2: 4.464/0.00807 |
3.557 | - | - | 0.852 | 0.980 | 0.822 | 0.903 | Mlig455_058728 {REF} {Length: 1351} {Pfam: CUB domain [PF00431.22, score=48.4]} {RNA1310_48745} {RNA815_23305} | |
74. | MligTC455_53504 | 217 | 4.51 | Mlig455_037385 | Neo: - Age: - Region-enriched R2: 3.142/0.00738 |
CSMD1 | 3.555 | - | - | 0.778 | 0.977 | 0.867 | 0.933 | Mlig455_037385 {REF} {Length: 2214} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=198.7]} {Human: ENSG00000183117, CSMD1, CUB and Sushi multiple domains 1, [Score=149, Expect=8e-37]} {Mouse: ENSMUSG00000028369, Svep1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=136, Expect=7e-33]; ENSMUSG00000060924, Csmd1, CUB and Sushi multiple domains 1, [Score=134, Expect=5e-32]; ENSMUSG00000022311, Csmd3, CUB and Sushi multiple domains 3, [Score=133, Expect=9e-32]} {Dmel: FBgn0032797, Hasp, Hig-anchoring scaffold protein, [RH, Score=218, Expect=3e-60]} {Celegans: WBGene00002976, lev-9, [RH, Score=244, Expect=4e-72]} {Smed: dd_Smed_v6_13071_0_1, dd_Smed_v6_13071_0_1, [RH, Score=296, Expect=1e-91]} {RNA1509_55985} {RNA1310_12867.1, RNA1509_55985} {RNA1509_55985, RNA815_9157} |
75. | MligTC455_40610 | 165 | 3.43 | Mlig455_064484 | Neo: - Age: - Region-enriched R2: 5.617/0.00105 |
3.554 | - | - | 0.846 | 0.756 | 0.953 | 0.999 | Mlig455_064484 {REF} {Length: 2931} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=24.9]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=154, Expect=2e-40]} {RNA1509_26568} {RNA1310_9342.1, RNA1509_26568} {RNA1509_26568, RNA815_7018} | |
76. | MligTC455_46924 | 1562 | 32.53 | Mlig455_042561 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.240 Region-enriched R2: 5.226/0.00021 |
PI16 | 3.548 | 0.826 | - | 0.863 | 0.875 | - | 0.984 | Mlig455_042561 {REF} {Length: 1929} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=59.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=75.5, Expect=4e-14]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=78.6, Expect=3e-15]; ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=75.1, Expect=5e-15]} {Dmel: FBgn0038126, CG8483, [Score=65.9, Expect=2e-11]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.9, Expect=7e-12]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=140, Expect=2e-36]} {RNA1509_33691, RNA1509_4403} {RNA1310_19427.1, RNA1509_33691, RNA1509_4403} {RNA1509_33691, RNA1509_4403, RNA815_7689.1} |
77. | MligTC455_26766 | 638 | 13.3 | Mlig455_017977 | Neo: - Age: Up-Down-Down Region-specific R2: 4.360 Region-enriched R2: 3.395/0.00052 |
3.547 | - | - | 0.948 | 0.714 | 0.891 | 0.994 | Mlig455_017977 {REF} {Length: 2516} {Smed: dd_Smed_v6_10627_0_1, dd_Smed_v6_10627_0_1, [Score=249, Expect=3e-71]} {RNA1509_19813} {RNA1310_621} {RNA815_183.1} | |
78. | MligTC455_44809 | 88 | 1.83 | Mlig455_035938 | Neo: - Age: - |
3.542 | - | - | 0.892 | 0.871 | 0.782 | 0.997 | Mlig455_035938 {REF} {Length: 1369} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} | |
79. | MligTC455_51763 | 1421 | 29.6 | Mlig455_015843 | Neo: - Age: - Region-specific R2: 3.066 Region-enriched R2: 2.560/0.00003 |
3.539 | - | - | 0.776 | 0.891 | 0.953 | 0.919 | Mlig455_015843 {REF} {Length: 805} {RNA1509_26419, RNA1509_39553, RNA1509_39658} {RNA1310_60107.2, RNA1509_26419, RNA1509_39553, RNA1509_39658} {RNA1509_26419, RNA1509_39553, RNA1509_39658, RNA815_31573} | |
80. | MligTC455_53682 | 393 | 8.18 | Mlig455_064952, Mlig455_066834 | Neo: - Age: Down-Up-Up Region-specific R2: 5.926 Region-enriched R2: 4.442/0.00896 |
3.538 | - | - | 0.791 | 0.796 | 0.979 | 0.972 | Mlig455_064952 {REF} {Length: 1573} {Pfam: PAN domain [PF00024.28, score=20.0]} {RNA1310_33258} {RNA815_17150} Mlig455_066834 {REF} {Length: 1573} {Pfam: PAN domain [PF00024.28, score=20.0]} {RNA1310_33258} {RNA815_17150} |
|
81. | MligTC455_52570 | 71 | 1.49 | Mlig455_066071 | Neo: - Age: Up-Down-Up |
3.536 | - | - | 0.918 | 0.777 | 0.842 | 0.999 | Mlig455_066071 {REF} {Length: 2575} {Pfam: Hemingway/CFA97 [PF13879.8, score=54.6]; Annexin [PF00191.22, score=26.1]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [Score=46.6, Expect=3e-06]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=70.1, Expect=2e-13]} {RNA1310_29320.1} {RNA815_54680} | |
82. | MligTC455_48756 | 622 | 12.96 | Mlig455_054772, Mlig455_054799, Mlig455_054893 | Neo: - Age: - Region-specific R2: 7.873 Region-enriched R2: 9.003/0.00000 |
3.531 | - | - | 0.938 | 0.805 | 0.789 | 0.999 | Mlig455_054772 {REF} {Length: 716} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054799 {REF} {Length: 625} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054893 {REF} {Length: 947} {RNA1509_41507} {RNA1310_49516, RNA1509_41507} {RNA1509_41507, RNA815_28703} |
|
83. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
3.53 | - | - | 0.953 | 0.867 | 0.756 | 0.954 | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
84. | MligTC455_18586 | 93 | 1.93 | Mlig455_020226 | Neo: - Age: Down-Down-Up |
3.523 | - | 0.808 | 0.857 | - | 0.877 | 0.981 | Mlig455_020226 {REF} {Length: 1261} {RNA1310_64121} {RNA815_32233} | |
85. | MligTC455_20722 | 36 | 0.74 | Mlig455_001696, Mlig455_066078, Mlig455_066120 | Neo: - Age: - |
3.522 | - | - | 0.787 | 0.866 | 0.886 | 0.983 | Mlig455_001696 {REF} {Length: 1535} {RNA1310_134737} {RNA815_57224} Mlig455_066078 {REF} {Length: 1438} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} {RNA1310_134737} {RNA815_57224} Mlig455_066120 {REF} {Length: 1438} {Pfam: Glycine rich protein [PF12810.9, score=25.9]} {RNA1310_134737} {RNA815_57224} |
|
86. | MligTC455_14831 | 280 | 5.83 | Mlig455_067864 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.261/0.00352 |
SSUH2 | 3.521 | - | - | 0.908 | 0.892 | 0.768 | 0.953 | Mlig455_067864 {REF} {Length: 1575} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=6e-54]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=7e-41]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=118, Expect=1e-29]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
87. | MligTC455_28693 | 60 | 1.26 | Mlig455_022354 | Neo: - Age: - |
3.52 | - | - | 0.886 | 0.775 | 0.862 | 0.997 | Mlig455_022354 {REF} {Length: 816} {Pfam: WSC domain [PF01822.21, score=53.0]; PAN domain [PF00024.28, score=20.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=48.1, Expect=2e-06]} {RNA1509_43359} {RNA1310_59466.1} {RNA815_19988} | |
88. | MligTC455_53860 | 202 | 4.22 | Mlig455_053523, Mlig455_061000 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.086/0.02665 |
RGS3 | 3.52 | - | - | 0.972 | 0.833 | 0.783 | 0.932 | Mlig455_053523 {REF} {Length: 2125} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=9e-51]} {RNA1310_19330.1} {RNA815_18723} Mlig455_061000 {REF} {Length: 2721} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]; Dehydrin [PF00257.21, score=20.5]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=8e-51]} {RNA1310_19330.1} {RNA815_18723} |
89. | MligTC455_41396 | 187 | 3.9 | Mlig455_012937, Mlig455_031470 | Neo: - Age: - Region-enriched R2: 4.167/0.01146 |
3.509 | - | - | 0.726 | 0.929 | 0.868 | 0.986 | Mlig455_012937 {REF} {Length: 1911} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [Score=46.6, Expect=1e-06]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} Mlig455_031470 {REF} {Length: 1745} {Dmel: FBgn0083971, CG34135, [RH, Score=60.1, Expect=1e-10]} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [RH, Score=96.3, Expect=3e-23]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} |
|
90. | MligTC455_16952 | 79 | 1.65 | Mlig455_001182 | Neo: - Age: - |
3.507 | - | - | 0.827 | 0.893 | 0.834 | 0.953 | Mlig455_001182 {REF} {Length: 3873} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [RH, Score=67.0, Expect=3e-14]} {RNA1509_4618} {RNA1310_46281} {RNA815_28578} | |
91. | MligTC455_39481 | 461 | 9.6 | Mlig455_056703, Mlig455_060318 | Neo: - Age: Down-Up-Up Region-specific R2: 4.222 |
ANGPTL1 | 3.505 | - | - | 0.741 | 0.826 | 0.942 | 0.996 | Mlig455_056703 {REF} {Length: 1114} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=79.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=89.4, Expect=1e-19]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=85.1, Expect=3e-18]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=91.3, Expect=2e-20]} {Dmel: FBgn0033312, CG8642, [Score=82.4, Expect=1e-17]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=76.3, Expect=1e-15]} {RNA1310_31288} {RNA815_20497.1} Mlig455_060318 {REF} {Length: 1175} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=106, Expect=2e-25]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=6e-26]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=109, Expect=1e-26]} {Dmel: FBgn0034160, CG5550, [Score=96.3, Expect=2e-23]} {Celegans: WBGene00016769, C49C8.5, [Score=47.0, Expect=9e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=88.2, Expect=2e-19]} {RNA1310_31288} {RNA815_20497.1} |
92. | MligTC455_50355 | 38 | 0.79 | Mlig455_057631 | Neo: - Age: - Region-enriched R2: 7.639/0.01837 |
3.505 | - | - | 0.759 | 0.840 | 0.909 | 0.997 | Mlig455_057631 {REF} {Length: 1003} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=6e-06]} {RNA1310_44307} {RNA815_33128} | |
93. | MligTC455_33854 | 41 | 0.85 | Mlig455_031601 | Neo: - Age: - Region-enriched R2: 5.730/0.00808 |
3.501 | - | - | 0.864 | 0.780 | 0.875 | 0.982 | Mlig455_031601 {REF} {Length: 1072} {RNA1310_42312} {RNA815_56269} | |
94. | MligTC455_41324 | 401 | 8.35 | Mlig455_024997 | Neo: - Age: Up-Down-Down |
CCDC151 | 3.501 | - | 0.871 | - | 0.822 | 0.837 | 0.971 | Mlig455_024997 {REF} {Length: 2376} {TRANSSPLICED} {Human: ENSG00000198003, CCDC151, coiled-coil domain containing 151, [Score=251, Expect=5e-75]} {Mouse: ENSMUSG00000039632, Ccdc151, coiled-coil domain containing 151, [Score=261, Expect=4e-79]} {Dmel: FBgn0036219, CCDC151, Coiled-coil domain containing protein 151, [Score=111, Expect=2e-25]} {Smed: dd_Smed_v6_4526_0_1, dd_Smed_v6_4526_0_1, [Score=463, Expect=3e-158]} {RNA1509_18758} {RNA1310_9513.1, RNA1509_18758} {RNA1509_18758, RNA815_13766} |
95. | MligTC455_16610 | 98 | 2.05 | Mlig455_069894 | Neo: - Age: - Region-enriched R2: 5.254/0.03136 |
WSCD2 | 3.499 | - | - | 0.873 | 0.818 | 0.809 | 0.999 | Mlig455_069894 {REF} {Length: 827} {Pfam: WSC domain [PF01822.21, score=59.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=55.1, Expect=4e-09]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=9e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.4, Expect=2e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
96. | MligTC455_36842 | 340 | 7.08 | Mlig455_056552 | Neo: - Age: - Region-enriched R2: 2.409/0.00668 |
SYT11 | 3.499 | - | - | 0.874 | 0.963 | 0.761 | 0.901 | Mlig455_056552 {REF} {Length: 3533} {Pfam: C2 domain [PF00168.32, score=153.6]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=310, Expect=7e-102]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=309, Expect=8e-102]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=355, Expect=3e-119]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=237, Expect=1e-74]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [Score=372, Expect=4e-127]} {RNA1509_16916, RNA1509_47189} {RNA1310_9964.1, RNA1509_16916, RNA1509_47189} {RNA1509_16916, RNA1509_47189, RNA815_17687} |
97. | MligTC455_52656 | 121 | 2.51 | Mlig455_062381, Mlig455_062408 | Neo: - Age: Down-Up-Down |
3.497 | - | - | 0.755 | 0.823 | 0.951 | 0.968 | Mlig455_062381 {REF} {Length: 2245} {RNA1310_26272} {RNA815_22826} Mlig455_062408 {REF} {Length: 2277} {RNA1310_26272} {RNA815_37592} |
|
98. | MligTC455_20953 | 115 | 2.4 | Mlig455_002904 | Neo: - Age: - Region-enriched R2: 5.041/0.00953 |
3.494 | - | - | 0.899 | 0.908 | 0.701 | 0.986 | Mlig455_002904 {REF} {Length: 1514} {RNA1310_19276} {RNA815_20827} | |
99. | MligTC455_39064 | 110 | 2.28 | Mlig455_000222, Mlig455_058480 | Neo: Irradiation Age: - Region-enriched R2: 5.418/0.00017 |
OSBPL1A | 3.494 | - | - | 0.797 | 0.933 | 0.791 | 0.973 | Mlig455_000222 {REF} {Length: 2113} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_7740} Mlig455_058480 {REF} {Length: 2888} {TRANSSPLICED} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_26411} |
100. | MligTC455_50777 | 40 | 0.83 | Mlig455_042072 | Neo: - Age: - |
MTNR1B | 3.493 | - | - | 0.923 | 0.871 | 0.707 | 0.992 | Mlig455_042072 {REF} {Length: 2881} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.0]; Olfactory receptor [PF13853.8, score=24.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]} {Human: ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=94.4, Expect=2e-21]; ENSG00000168412, MTNR1A, melatonin receptor 1A, [Score=90.1, Expect=5e-20]} {Mouse: ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=94.0, Expect=2e-21]; ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=89.4, Expect=6e-20]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=57.0, Expect=7e-09]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=52.0, Expect=2e-07]} {Smed: dd_Smed_v6_19535_0_1, dd_Smed_v6_19535_0_1, [Score=95.5, Expect=2e-22]} {RNA1310_66047} {RNA815_34066} |